Navigation Links
Iressa as Good as Chemotherapy for Lung Cancer
Date:11/21/2008

Daily pill easier to take, has fewer side effects than chemotherapy, experts say

FRIDAY, Nov. 21 (HealthDay News) -- The cancer-fighting pill Iressa works as well as chemotherapy as a second-line treatment for lung cancer, researchers report.

Although neither therapy prolongs survival beyond eight months, Iressa (gefitinib) causes fewer serious side effects and may be a better choice for patients who did not do well on their first round of chemotherapy.

"A pill, with less side effects, taken once a day, has similar activity to traditional chemotherapy given by vein every three weeks," said lead researcher Dr. Edward Kim, an assistant professor at the M. D. Anderson Cancer Center in Houston.

This finding should reassure doctors that they are not compromising effective therapy by using a pill, Kim said.

Iressa is not available in the United States, but a similar drug, Tarceva, is.

Iressa was first developed by AstraZeneca, but it failed to meet expectations. The National Cancer Institute ended clinical trials of the drug in 2005 because it failed to prolong the lives of lung cancer patients.

The latest finding has meaning for these patients, however, Kim said. "You can be treated for lung cancer. There are different therapies available, and they have different side-effect profiles," he said. "Chemotherapy will never be eliminated, but we are getting more options for targeted therapy; and people can live as normal a life as they can bearing the weight of lung cancer."

The report was published in the Nov. 22 issue of The Lancet.

In a head-to-head comparison, Kim's team randomly assigned 1,466 lung cancer patients who had undergone previous chemotherapy to daily doses of Iressa or the chemotherapy drug docetaxel once every three weeks.

The researchers found that survival in both groups of patients was about the same. Median survival for those taking Ir
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
2. Chemotherapy may be culprit for fatigue in breast cancer survivors
3. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
4. To evade chemotherapy, some cancer cells mimic stem cells
5. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
6. PET scans can accurately detect a breast tumors response to chemotherapy
7. Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
8. Medicare modernization act did not change chemotherapy as feared
9. HER-2 status predicts success of chemotherapy in breast cancer treatment, study finds
10. Cancer conflict with chemotherapy treatment
11. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Iressa as Good as Chemotherapy for Lung Cancer
(Date:8/22/2014)... The report "Higher Education Market [Software Solutions, ... Technology, Student & Curriculum, Performance Management] - Worldwide ... the global Higher Ed market into various sub-segments ... sizes. The report also identifies the factors driving ... along with the adoption trends. , Browse ...
(Date:8/22/2014)... 2014 A new study finds a wide range ... be related to key environmental exposuresin children with Crohn,s disease ... journal of the Crohn,s & Colitis Foundation of America ... Williams & Wilkins , a part of Wolters Kluwer ... of alterations of DNA in several regions of the genome ...
(Date:8/22/2014)... disease can be slowed and some of its ... found in pomegranate. Also, the painful inflammation ... Parkinson,s disease could be reduced, according to the ... of Huddersfield scientist Dr Olumayokun Olajide, who specialises ... Now, a new phase of research can explore ...
(Date:8/22/2014)... at New York University,s Langone Medical Center (NYULMC) heroically ... youngest and most vulnerable down flights of stairs during ... by Hurricane Sandy. , Now, a recent study ... Nursing (NYUCN) and of Dentistry (NYUCD), published in ... on NYULMC nurses, post-Sandy deployment to help address patient ...
(Date:8/22/2014)... for Medical Oncology (ESMO), the leading pan-European organisation ... of three outstanding individuals receiving the Society,s esteemed ... Carsten Bokemeyer, Heikki Joensuu and Peter Boyle on ... September, Madrid, Spain. , Carsten Bokemeyer will receive ... the transition of cancer discovery into real benefit ...
Breaking Medicine News(10 mins):Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 3Health News:ESMO honours outstanding oncology professionals 2Health News:ESMO honours outstanding oncology professionals 3
... WALTHAM, Mass., Oct. 13 Interleukin Genetics, Inc. (NYSE Amex: ... the fields of obesity and osteoporosis at medical meetings later this ... (ADA) Food and Nutrition Conference & Expo in Denver, Colo. ... IDF 20th World Diabetes Congress - Montreal, Canada . , ...
... ventilation be avoided during an infectious outbreak, the author ... ) in CMAJ ( Canadian Medical Association ... be used expeditiously in this setting. Noninvasive ... of patients in respiratory failure, rather than a tube ...
... ... a healthy neutral body posture by transforming existing office chairs into ergonomic computer workstations ... Salisbury, NC ... announced today the availability of the Mobo® , a revolutionary computer accessory that ...
... ... OxiTitan VLR : A new weapon in the battle against ... bacteria on treated surfaces. OxiTitan VLR is a broad spectrum mineral ... trap, oxidize and kill microbes. Safe and eco-friendly OxiTitan VLR is ...
... On Wednesday, October 14, the American Muslim Taskforce ... major national Islamic organizations, will host an "Interfaith Hearing ... D.C. , The hearing, which will include presentations by ... of Congress, is designed to mobilize support for "genuine ...
... The Blue Cross and Blue Shield of Georgia Foundation ... the Georgia Flood Relief Effort. , Strong storms and continued ... metro Atlanta and its surrounding areas - with more than ... Chattooga, Cherokee, Clayton, Cobb, Crawford, DeKalb, Douglas, Forsyth, Fulton, Gwinnett, ...
Cached Medicine News:Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 2Health News:Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings 3Health News:Should noninvasive ventilation be considered a high-risk procedure during an epidemic? 2Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 2Health News:Ergobiz Announces The Mobo Ergonomic Computer Station 3Health News:Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 2Health News:Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces 3Health News:DC: Muslim Coalition to Host Interfaith Hearing on Health Care 2Health News:Blue Cross and Blue Shield of Georgia Foundation Donates $25,000 to Red Cross for Flood Relief Efforts in Georgia 2
(Date:8/21/2014)... 21, 2014   Memorial Hermann Health System and ... today announced a new partnership to provide a new level ... care centers in the greater Houston ... become the exclusive provider of professional breast radiology services for ... Memorial City, The Woodlands , Northeast, Southwest ...
(Date:8/21/2014)... , Aug. 21, 2014 Nektar Therapeutics ... Inc. today announced positive results from its Phase ... investigational, extended half-life recombinant factor VIII (rFVIII) treatment ... (Recombinant)], which met its primary endpoint in reducing ... compared to the on-demand arm. Top-line ...
(Date:8/21/2014)... , Aug. 21, 2014 The spinal column is ... human body. Signals carried to and from the brain through ... and nervous system. Injury or ailment here can be life ... a loss of control over their body. Though back injury ... person,s life, there are more options available to make things ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2
... (NYSE: WPI ), a leading specialty pharmaceutical ... Chief Executive Officer, will provide an overview and update ... Global Healthcare Conference on Tuesday, March 13, 2012 at ... in Miami, Florida.  The presentation will be webcast live ...
... March 1, 2012  Heritage Provider Network presented checks totaling ... Health Prize competition at the Strata Conference in Santa ... 12 month mark. Once again, the ... winning the top spot.  Players include David Vogel, CEO ...
Cached Medicine Technology:Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 2Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 3
... MRAnywhere stands for Medical ... Electronic Medical Records (EMR) software ... charts from within your office, ... Wide Web. MRAnywhere offers conversion ...
... Pro Software developed a touchscreen EHR and ... While a user can choose to use ... to maintain eye contact while recording encounter ... Pro EHR also runs on a pen ...
... designed to improve the efficiency and quality ... the ability to capture and recall patient ... audio or video formats. As an electronic ... contemporary windows interface and is compatible with ...
... Dairylands Clinical Information ... a suite of integrated ... clinical departments and automate ... tasks. The applications allow ...
Medicine Products: